MedTrace Logo

Laser Treatment of Acne Scars in Fitzpatrick Skin Types III-VI

NCT01221922 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-11-28

No results posted yet for this study

Summary

The purpose of this study is to evaluate the RevLite Q-Switched Neodymium: Yttrium-Aluminum-Garnet (Nd:YAG) Laser in the treatment of acne scars in darker skin types (Fitzpatrick Skin Types III, IV, V and VI).

Conditions

  • Acne Scars

Interventions

DEVICE

RevLite Q-Switched Nd:YAG Laser

Laser treatment once every 2 weeks for a total of 10 treatments.

Sponsors & Collaborators

  • ConBio, a Cynosure Company

    lead INDUSTRY

Principal Investigators

  • Niwat Polnikorn, MD · Kasemrad Aesthetic Center, Thailand

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01221922 on ClinicalTrials.gov